Professor of Medicine and Pediatrics; Perelman School of Medicine at the University of Pennsylvania
Nephrology
Dr. Jeffrey S. Berns, MD
|
|
Give Review
Jeffrey S. Berns, MD is an expert in the field of Nephrology. He went to medical school at Yale University School of Medicine. Yale University School of Medicine is one of the top medical schools in the US. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He has 6 awards "America's Top Doctors", "Philadelphia Magazine", "CMS Meaningful Use Stage 1 Certification", "Fellow (ASNF)", "Super Doctor" and "Top MD". Jeffrey Berns is a published doctor and has 101 publications published. The lastest was: 'The application of job satisfaction theory to the nursing profession.' He accepts all Medicare patients.
Publications
- The Native Kidney Biopsy: Update and Evidence for Best Practice.
- Clinical Decision Making in a Patient With Stage 5 CKD-Is eGFR Good Enough?
- Moving away from hemoglobin-based anemia performance measures in dialysis patients.
- Routine Screening for CKD Should Be Done in Asymptomatic Adults ⦠Selectively.
- Measuring Vitamin, Mineral, and Trace Element Levels in Dialysis Patients.
- Training the Next Generation's Nephrology Workforce.
- Are We Paying Our Housestaff Fairly?
- Should Nephrology Training Programs Continue to Train Fellows in the Placement of Temporary Hemodialysis Catheters?
- Dialysis versus Nondialysis in Patients With AKI: A Propensity-Matched Cohort Study.
- Cancer and the Kidney: The Growth of Onco-nephrology.
- Tumor lysis syndrome: new challenges and recent advances.
- Chronic Kidney disease in patients with renal cell carcinoma.
- Dabigatran and Kidney Disease: A Bad Combination.
- Is eliminating the floor for the Hb range consistent With patient-centered care?
- Handoff communication between hospital and outpatient dialysis units at patient discharge: a qualitative study.
- Can Frequent Hemodialysis Be Too Frequent?
- Onco-Nephrology: Tumor Lysis Syndrome.
- Red Blood Cell Transfusion Risks in Patients with End-Stage Renal Disease.
- A SHARP Study, But With Blunted Conclusions.
- APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy.
- The Renal Manifestations of Thyroid Disease.
- Do oral iron supplements have any role in dialysis patients?
- A New CJASN Feature: Attending Rounds Series.
- Staphylococcus-Infected Tunneled Dialysis Catheters: Is Over-the-Wire Exchange an Appropriate Management Option?
- Extracorporeal treatment of cast nephropathy.
- Initiating dialysis at the right time: is the evidence IDEAL?
- The ASN in-training examination needs more time, not a new paradigm.
- KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
- Selection and dosing of medications for management of diabetes in patients with advanced Kidney disease.
- A survey-based evaluation of self-perceived competency after nephrology fellowship training.
- Erythropoietin bundling: innovative remuneration or the dawn of EPO-profiling?
- KDOQI in the era of global guidelines.
- Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO.
- Impact of obstructive sleep apnea in hemodialysis patients.
- Is angiotensin-converting enzyme inhibitor and angiotensin receptor blocker combination therapy better than monotherapy and safe in patients With CKD?
- Activated vitamin D: does it explain an apparent survival advantage among black and hispanic hemodialysis patients?
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
- Viral nephropathies: core curriculum 2008.
- Recruitment of live donors by candidates for Kidney transplantation.
- Performance of procedures by nephrologists and nephrology fellows at U.S. nephrology training programs.
- Niacin and related compounds for treating hyperphosphatemia in dialysis patients.
- History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among Chronic hemodialysis patients.
- How much is enough? The impact of frequent hemodialysis.
- NPHS2 variation in sporadic focal segmental glomerulosclerosis.
- Impact of tip culture on the management of infected tunneled hemodialysis catheters.
- Quinine--a tonic too bitter for hemodialysis-associated muscle cramps?
- Arterial stiffness and vascular calcification in dialysis patients: new measures of cardiovascular risk.
- Viruses and diseases of the Kidneys.
- CHOIR, CREATE, and anemia treatment in patients With CKD.
- What is the nephrologist's role as a primary care provider? We all have different answers.
- Can continuous venovenous hemofiltration prevent contrast-induced nephropathy: is the dye already cast?
- Spontaneous tumor lysis syndrome in Acute myeloid leukemia: two cases and a review of the literature.
- That catheter is going to cost you!
- Use of antiepileptic drugs in patients with Kidney disease.
- How can erythropoietin requirements be reduced in dialysis patients?
- The safety of heparins in end-stage renal Disease.
- When chronic Kidney disease becomes advanced. Guidelines for care in the emergency department and hospital.
- Hemoglobin variability: random fluctuation, epiphenomenon, or phenomenon?
- Should all patients with chronic Kidney disease receive an EPO-type drug?
- Boning up on lanthanum.
- Highly active antiretroviral therapy and the Kidney: an update on antiretroviral medications for nephrologists.
- How should Chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
- Single-center experience With the Arrow-Trerotola Percutaneous Thrombectomy Device in the management of thrombosed native dialysis fistulas.
- Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time.
- Hemoglobin cycling in hemodialysis patients treated With recombinant human erythropoietin.
- Are inflammatory cytokines the "evil humors" that increase morbidity and cardiovascular mortality in chronic Kidney disease?
- Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients.
- Variants in the Wilms' tumor gene are associated With focal segmental glomerulosclerosis in the African American population.
- Should the target hemoglobin for patients with chronic Kidney disease treated with erythropoietic replacement therapy be changed?
- Use of low molecular weight heparins and glycoprotein IIb/IIIa inhibitors in patients with chronic Kidney disease.
- Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced Kidney disease.
- Willingness of patients to switch from conventional to daily hemodialysis: looking before we leap.
- Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis.
- Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients.
- Hemoglobin variability in epoetin-treated hemodialysis patients.
- Clinical evaluation of heme iron polypeptide: sustaining a Response to rHuEPO in hemodialysis patients.
- Complications of percutaneous treatment of thrombosed hemodialysis access grafts.
- Infection With antimicrobial-resistant microorganisms in dialysis patients.
- Preventing bacterial Infections and antimicrobial resistance in dialysis patients.
- Is intravenous iron safe in patients with liver Disease?
- Review: angiotensin-converting enzyme inhibitors reduce the progression of nondiabetic renal Disease.
- Development, implementation, and results of the ASN in-training examination for fellows.
- Effect of darbepoetin alfa on endothelial progenitor cells and vascular reactivity in chronic Kidney disease.
- Are there implications from the Trial to Reduce Cardiovascular Events With Aranesp Therapy study for anemia management in dialysis patients?
- Evidence and implications of haemoglobin cycling in anaemia management.
- Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis.
- The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients.
- Duplication 6q syndrome.
- Recurrent lower abdominal pain in a middle-aged man.
- Inherited hemolytic uremic syndrome in adults.
- A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on Chronic hemodialysis.
- Hypoglycemia with hyperinsulinemia in a Chronic hemodialysis patient following parathyroidectomy.
- Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.
- Removal of myoglobin by CAVH-D in traumatic rhabdomyolysis.
- Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal Disease.
- Normal splenic function in children With the nephrotic syndrome.
- Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth.
- Progression of orthostatic proteinuria to focal and segmental glomerulosclerosis.
- Nonsurgical cure of pulmonary mucormycosis.
- The application of job satisfaction theory to the nursing profession.
Schools
Case Western Reserve University School of Medicine
University Hospital Cleveland
Yale University School Of Med
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- America's Top Doctors
- Philadelphia Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (ASNF)
- Super Doctor
- Top MD
Education
-
Yale University School of Medicine -
Case Western Reserve University - University Hospitals -
Case Western Reserve University School of Medicine
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1386650299 | |
| NPPES Provider LastName | BERNS | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 191042640 | |
| NPPES Provider State | PA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 537.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 2.98 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386650299 |
| Last Name Of The Provider | BERNS |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. Amit A. Deshpande, MD |
|
Dr. Thomas C. Delgiorno, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellie Kelepouris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bonita A. Mohamed, MD |
|
|
Dr. Kenneth A. Knowles, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dan Negoianu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bernard E. Ilson, MD |
|
|
Dr. Sandra Levison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamanna H. Kalra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey W. Dubb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Imara R. Dissanayake, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry E. Krevolin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph H. Brezin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Debbie L. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa Bleicher, MD
This Doctor is OpenDoctor Recommended.
|